Sockel will leverage 25 years of sales, product and operations leadership to drive revenue and market growth at NovuHealth MINNEAPOLIS, Nov. 14, 2019 (GLOBE NEWSWIRE) -- NovuHealth

BATON ROUGE, La., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 Jefferies London Healthcare Conference in London, England on Wednesday, November 20, 2019. Th

MARKHAM, Ontario, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three and nine months ended September 30, 2019. The Unaudited Condensed Interim Consolidated Financial Statements and accompanying Management’s Discussi

LAFAYETTE, La., Nov. 13, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that Mohammad Ali (“Ali”) will join the company, effective Dec. 2, 2019, as chief information officer (CIO). Ali will oversee LHC Group’s information technology (IT) strategy and implementation in support of the company’s ongoing gro

EAGLE, Idaho, Nov. 12, 2019 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the third quarter of 2019, reporting GAAP earnings per share of $0.06 for the quarter and adjusted earnings per share of $0.16 fo

AVISE® Testing Revenue Drives 27% Revenue Growth SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervent

Total Net Revenue (“Revenue”) increased 20.9% to $292.7 million in the third quarter of 2019 from $242.1 million in the third quarter of 2018Adjusted EBITDA(1) increased 7.7% to $41.0 million in the third quarter of 2019 from $38.1 million in the third quarter of 2018  Earnings Per Share was

NORCROSS, Ga., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended September 30, 2019. These results are included in the Company's Quarterly Report on Form 10-Q, which has been file

LAFAYETTE, La., Nov. 12, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Stephens Nashville Investment Conference in Nashville, Tenn. on Friday, November 15, 2019 at 9:45 a.m. Central time and a

NORCROSS, Ga., Nov. 11, 2019 (GLOBE NEWSWIRE) -- Today, Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced a collaboration agreement with Siemens Healthineers, a global leader in medical technology, in nonalcoholic steatohepatitis (NASH) and liver fibrosis. This collaboration allows Siemens Hea